The association of gastric cancer risk with plasma folate, cobalamin, and methylenetetrahydrofolate reductase polymorphisms in the European Prospective Investigation into Cancer and Nutrition.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsVollset, Stein Emil
Gjessing, Hakon K.
Ueland, Per Magne
Del Giudice, Giuseppe
Bueno-de-Mesquita, H. Bas
Quirós, Jose R.
Key, Timothy J.
Buchner, Frederike L.
Peeters, Petra H.M.
Numans, Mattijs E.
Gonzalez, Carlos A.
MetadataShow full item record
AbstractPrevious studies have shown inconsistent associations of folate intake and polymorphisms of the methylenetetrahydrofolate reductase (MTHFR) gene with gastric cancer risk. Our nested case-control study within the European Prospective Investigation into Cancer and Nutrition cohort is the first prospective study of blood folate levels and gastric cancer. Gastric cancer cases (n=247) and controls (n=631) were matched for study center, age, sex, and time of blood donation. Two common single nucleotide polymorphisms of the MTHFR gene were determined, as were plasma concentrations of folate, cobalamin (vitamin B12), total homocysteine, and methylmalonic acid (cobalamin deficiency marker) in prediagnostic plasma. Risk measures were calculated with conditional logistic regression. Although no relations were observed between plasma folate or total homocysteine concentrations and gastric cancer, we observed a trend toward lower risk of gastric cancer with increasing cobalamin concentrations (odds ratio, 0.79 per SD increase in cobalamin; P=0.01). Further analyses showed that the inverse association between cobalamin and gastric cancer was confined to cancer cases with low pepsinogen A levels (marker of severe chronic atrophic gastritis) at the time of blood sampling. The 677 C-->T MTHFR polymorphism was not associated with gastric cancer, but we observed an increased risk with the variant genotype of the 1298 A-->C polymorphism (odds ratio, 1.47 for CC versus AA; P=0.04). In conclusion, we found no evidence of a role of folate in gastric cancer etiology. However, we observed increased gastric cancer risk at low cobalamin levels that was most likely due to compromised cobalamin status in atrophic gastritis preceding gastric cancer.
CitationCancer Epidemiol. Biomarkers Prev. 2007, 16 (11):2416-2424
JournalCancer Epidemiology, Biomarkers & Prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
- Polymorphisms of methylenetetrahydrofolate reductase and the risk of prostate cancer: a nested case-control study.
- Authors: Van Guelpen BR, Wirén SM, Bergh AR, Hallmans G, Stattin PE, Hultdin J
- Issue date: 2006 Feb
- Effects of folic acid fortification and multivitamin therapy on homocysteine and vitamin B(12) status in cardiac transplant recipients.
- Authors: Miriuka SG, Langman LJ, Keren ES, Miner SE, Mamer OA, Delgado DH, Evrovski J, Ross HJ, Cole DE
- Issue date: 2004 Apr
- Gene polymorphisms of folate metabolizing enzymes and the risk of gastric cancer.
- Authors: Götze T, Röcken C, Röhl FW, Wex T, Hoffmann J, Westphal S, Malfertheiner P, Ebert MP, Dierkes J
- Issue date: 2007 Jun 28
- Methylenetetrahydrofolate reductase (MTHFR) c677t gene variant modulates the homocysteine folate correlation in a mild folate-deficient population.
- Authors: Pereira AC, Schettert IT, Morandini Filho AA, Guerra-Shinohara EM, Krieger JE
- Issue date: 2004 Feb
- Dietary folate and vitamin B12 intake before diagnosis decreases gastric cancer mortality risk among susceptible MTHFR 677TT carriers.
- Authors: Galván-Portillo MV, Oñate-Ocaña LF, Pérez-Pérez GI, Chen J, Herrera-Goepfert R, Chihu-Amparan L, Flores-Luna L, Mohar-Betancourt A, López-Carrillo L
- Issue date: 2010 Feb